Biological drugs, like trastuzumab are tough to perfectly replicate Alfred Pasieka/Science Photo Library
BIOLOGICAL drugs are the new darlings of medicine. In recent years, they have doubled treatment rates for several , and . But these medicines, which are large, complex molecules produced by living cells, carry hefty price tags, and now comprise eight of the world’s .
A one-year course of the biological breast cancer drug trastuzumab (sold as Herceptin), for example, costs $50,000. In the UK, biologics have contributed to a
